San Angelo
San Angelo
San Angelo, Texas, United States6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TECTONIC CAD IVL IDE Study | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2026-09-08 | NCT06885177 | |
| The ION Facet Screw System Ambispective Evaluation | Intra-facet ION 3D Facet Screw System | Enrolling by invitation | Not stated | 2026-08-24 | NCT06720948 | |
| A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 3 | 2026-04-13 | NCT07300839 | |
| XIENCE Skypoint Large Vessel Post Approval Study | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not stated | 2026-02-24 | NCT05423379 | |
| A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 3 | 2026-01-21 | NCT05026866 | |
| A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine | Alphavirus infectious disease, Encephalitis, Arbovirus, Encephalitis, Viral, Encephalomyelitis, Equine, Infections, Mosquito-Borne Diseases, Neuroinflammatory Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, encephalomyelitis, infectious encephalitis, nervous system disorder, vector-borne disease, viral infection of central nervous system, viral infectious disease | Active, not recruiting | Phase 2 | 2025-10-01 | NCT06899802 |